Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
20800 | 445 | 26.3 | 73% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
216 | 3 | NON SMALL CELL LUNG CANCER//LUNG CANCER//THORAC SURG | 51214 |
3290 | 2 | HAND FOOT SYNDROME//HYPERSENSITIVITY REACTION//RADIATION RECALL | 1872 |
20800 | 1 | HYPERSENSITIVITY REACTION//HYPERSENSITIVITY//RAPID DESENSITIZATION | 445 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HYPERSENSITIVITY REACTION | authKW | 1759400 | 20% | 29% | 88 |
2 | HYPERSENSITIVITY | authKW | 261480 | 20% | 4% | 87 |
3 | RAPID DESENSITIZATION | authKW | 224144 | 2% | 47% | 7 |
4 | CARBOPLATIN HYPERSENSITIVITY | authKW | 219575 | 1% | 80% | 4 |
5 | CARBOPLATIN DESENSITIZATION | authKW | 205854 | 1% | 100% | 3 |
6 | CARBOPLATIN | authKW | 149341 | 17% | 3% | 75 |
7 | ACUTE HYPERSENSITIVITY REACTIONS | authKW | 137236 | 0% | 100% | 2 |
8 | CHEMOTHERAPY DESENSITIZATION | authKW | 137236 | 0% | 100% | 2 |
9 | PACLITAXEL HYPERSENSITIVITY | authKW | 137236 | 0% | 100% | 2 |
10 | RAPID DRUG DESENSITIZATION | authKW | 137236 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Allergy | 7031 | 19% | 0% | 83 |
2 | Oncology | 3729 | 47% | 0% | 211 |
3 | Immunology | 551 | 18% | 0% | 81 |
4 | Obstetrics & Gynecology | 477 | 11% | 0% | 47 |
5 | Pharmacology & Pharmacy | 332 | 18% | 0% | 80 |
6 | Pediatrics | 89 | 6% | 0% | 26 |
7 | Medicine, General & Internal | 64 | 7% | 0% | 32 |
8 | Hematology | 50 | 4% | 0% | 18 |
9 | Rheumatology | 30 | 2% | 0% | 8 |
10 | Rehabilitation | 27 | 2% | 0% | 9 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ADVERSE DRUG REACT DESENSITIZAT PROGRAM | 91489 | 0% | 67% | 2 |
2 | ALLERGOL ONCOL SERV | 91489 | 0% | 67% | 2 |
3 | ALLERGY IMMUNOL TRAINING PROGRAM MED | 68618 | 0% | 100% | 1 |
4 | ALLERGY IMMUNOLSIRIRAJ HOSP | 68618 | 0% | 100% | 1 |
5 | ALLERGY PEDIAT IMMUNOL | 68618 | 0% | 100% | 1 |
6 | ALLERGY UNITHOSP CLIN ICT | 68618 | 0% | 100% | 1 |
7 | ALLERGY UNITPNEUMOL P HOSP CLIN ICT | 68618 | 0% | 100% | 1 |
8 | AOU S GIOVANNI BATTISTA MOLINETTE | 68618 | 0% | 100% | 1 |
9 | ARTHRIT RHEUMATISM CLIN | 68618 | 0% | 100% | 1 |
10 | BRIGHAM WOMENS HOSPALLERGY IMMUNOL TRAINING PR | 68618 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 9123 | 2% | 2% | 7 |
2 | GYNECOLOGIC ONCOLOGY | 4058 | 6% | 0% | 26 |
3 | JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY | 3038 | 2% | 1% | 8 |
4 | MEDICAL AND PEDIATRIC ONCOLOGY | 2211 | 2% | 0% | 9 |
5 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 1851 | 2% | 0% | 11 |
6 | CURRENT ALLERGY AND ASTHMA REPORTS | 1751 | 1% | 1% | 5 |
7 | ANTI-CANCER DRUGS | 1690 | 2% | 0% | 9 |
8 | JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 1439 | 3% | 0% | 15 |
9 | INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY | 1401 | 1% | 0% | 5 |
10 | ATENCION FARMACEUTICA | 1267 | 0% | 1% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CAIADO, J , CASTELLS, M , (2015) PRESENTATION AND DIAGNOSIS OF HYPERSENSITIVITY TO PLATINUM DRUGS.CURRENT ALLERGY AND ASTHMA REPORTS. VOL. 15. ISSUE 4. P. - | 63 | 72% | 0 |
2 | MIYAMOTO, S , OKADA, R , ANDO, K , (2015) PLATINUM HYPERSENSITIVITY AND DESENSITIZATION.JAPANESE JOURNAL OF CLINICAL ONCOLOGY. VOL. 45. ISSUE 9. P. 795 -804 | 61 | 69% | 1 |
3 | PICARD, M , MATULONIS, UA , CASTELLS, M , (2014) CHEMOTHERAPY HYPERSENSITIVITY REACTIONS IN OVARIAN CANCER.JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK. VOL. 12. ISSUE 3. P. 389 -402 | 56 | 71% | 1 |
4 | CAIADO, J , PICARD, M , (2014) DIAGNOSTIC TOOLS FOR HYPERSENSITIVITY TO PLATINUM DRUGS AND TAXANES: SKIN TESTING, SPECIFIC IGE, AND MAST CELL/BASOPHIL MEDIATORS.CURRENT ALLERGY AND ASTHMA REPORTS. VOL. 14. ISSUE 8. P. - | 51 | 54% | 3 |
5 | TOKI, MI , SAIF, MW , SYRIGOS, KN , (2014) HYPERSENSITIVITY REACTIONS ASSOCIATED WITH OXALIPLATIN AND THEIR CLINICAL MANAGEMENT.EXPERT OPINION ON DRUG SAFETY. VOL. 13. ISSUE 11. P. 1545 -1554 | 41 | 67% | 1 |
6 | BALDO, BA , PAGANI, M , (2014) ADVERSE EVENTS TO NONTARGETED AND TARGETED CHEMOTHERAPEUTIC AGENTS EMPHASIS ON HYPERSENSITIVITY RESPONSES.IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA. VOL. 34. ISSUE 3. P. 565 -+ | 44 | 60% | 4 |
7 | BERGAMINI, A , PISANO, C , DI NAPOLI, M , ARENARE, L , DELLA PEPA, C , TAMBARO, R , FACCHINI, G , GARGIULO, P , ROSSETTI, S , MANGILI, G , ET AL (2017) CISPLATIN CAN BE SAFELY ADMINISTERED TO OVARIAN CANCER PATIENTS WITH HYPERSENSITIVITY TO CARBOPLATIN.GYNECOLOGIC ONCOLOGY. VOL. 144. ISSUE 1. P. 72 -76 | 30 | 83% | 0 |
8 | KHURANA, A , MITSIS, D , KOWLGI, GN , HOLLE, LM , CLEMENT, JM , (2016) ATYPICAL PRESENTATION OF FEVER AS HYPERSENSITIVITY REACTION TO OXALIPLATIN.JOURNAL OF ONCOLOGY PHARMACY PRACTICE. VOL. 22. ISSUE 2. P. 319 -324 | 29 | 81% | 1 |
9 | BOULANGER, J , BOURSIQUOT, JN , COURNOYER, G , LEMIEUX, J , MASSE, MS , ALMANRIC, K , GUAY, MP , (2014) MANAGEMENT OF HYPERSENSITIVITY TO PLATINUM- AND TAXANE-BASED CHEMOTHERAPY: CEPO REVIEW AND CLINICAL RECOMMENDATIONS.CURRENT ONCOLOGY. VOL. 21. ISSUE 4. P. E630 -E641 | 40 | 63% | 4 |
10 | THAM, EH , CHENG, YK , TAY, MH , ALCASABAS, AP , SHEK, LPC , (2015) EVALUATION AND MANAGEMENT OF HYPERSENSITIVITY REACTIONS TO CHEMOTHERAPY AGENTS.POSTGRADUATE MEDICAL JOURNAL. VOL. 91. ISSUE 1073. P. 145 -150 | 33 | 72% | 0 |
Classes with closest relation at Level 1 |